Age, marital status, tumor site, AJCC stage, T stage, N stage, M stage, surgery, radiotherapy, and chemotherapy all demonstrated statistically significant variations in survival prognostic variables, in the univariate analysis, but the sex (p=0.700), race (p=0.131), PR status (p=0.312), ER status (p=0.296), HER-2 status(p=0.518) and subtype (p=0.913). This evidence concerns the gene ERBB2 and neoplasm.